Join the Non-Small Cell Lung Cancer group to help and get support from people like you.
Non-Small Cell Lung Cancer News (Page 4)
Related terms: Cancer, Lung, Non-Small Cell, Lung Cancer, Non-Small Cell, NSCLC
Study IDs Downstream Procedure, Complication Rates After Lung Cancer Screening
TUESDAY, Jan. 2, 2024 – For individuals undergoing low-dose computed tomography (LDCT) scans for lung cancer screening (LCS), the rates of downstream procedures and complications are higher than...
Study Looks at Survival in Metastatic NSCLC Treated With Immunotherapy
WEDNESDAY, Dec. 13, 2023 – For patients with metastatic non-small cell lung cancer (NSCLC) receiving immunotherapy, outcomes are similar across racial and ethnic groups, but ECOG performance status...
Monthly News Roundup - November 2023
FDA Approves Lilly’s Zepbound for Chronic Weight Management In November, the U.S. Food and Drug Administration (FDA) approved Eli Lilly’s Zepbound (tirzepatide), a glucose-dependent insulinotropic pol...
AI Could Predict a Nonsmoker's Risk for Lung Cancer
WEDNESDAY, Nov. 22, 2023 – Artificial intelligence (AI) can help assess lung cancer risk in nonsmokers, a new study shows. The “CXR-Lung-Risk” AI program evaluates routine chest X-ray images, loo...
Study Identifies Familial Germline EGFR T790M Variant in Lung Cancer
FRIDAY, Nov. 17, 2023 – A new familial lung cancer caused by an inherited mutation in EGFR has been described in a study published online Oct. 23 in the Journal of Clinical Oncology. Geoffrey R....
Osimertinib + Chemo Improves Progression-Free Survival in Advanced NSCLC
THURSDAY, Nov. 16, 2023 – For patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), osimertinib with chemotherapy leads to significantly longer progression-free survival (PFS)...
FDA Approves Augtyro (repotrectinib) for the Treatment of Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer (NSCLC)
PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Augtyro (repotrectinib) for the treatment of adult...
Rate of New Lung Cancer Cases Has Decreased Over Last Five Years
TUESDAY, Nov. 14, 2023 – The rate of new lung cancer cases has decreased and survival has improved over the last five years, according to the State of Lung Cancer 2023 report published Nov. 14 by...
2023 Guidelines Update Eligibility for Lung Cancer Screening
THURSDAY, Nov. 9, 2023 – In a guideline update issued by the American Cancer Society and published online Nov. 1 in CA: A Cancer Journal for Clinicians, the authors recommend increasing eligibility...
CT Screening Greatly Boosts Lung Cancer Survival: Study
WEDNESDAY, Nov. 8, 2023 – For smokers and former smokers, getting annual CT scans of the chest to catch lung cancers early dramatically improves survival, new research shows. Many people may believe...
Experts Widen Criteria for Those Who Should Get Lung Cancer Screening
THURSDAY, Nov. 2, 2023 – The American Cancer Society has expanded its recommendations for who should get lung cancer screening. The updated guidance now says annual screening should start at a...
FDA Moves Closer to Banning Menthol Cigarettes, Flavored Cigars
TUESDAY, Oct. 17, 2023 – A proposed rule from federal regulators that would ban menthol cigarettes and flavored cigars has been sent to the White House Office of Management and Budget for final r...
FDA Approves Keytruda (pembrolizumab) for Treatment of Patients With Resectable NSCLC in Combination With Chemotherapy as Neoadjuvant Treatment, Then Single Agent as Adjuvant Treatment After Surgery
RAHWAY, N.J.--(BUSINESS WIRE) October 16, 2023 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has...
Incidence of Lung Cancer Higher in Women Versus Men Aged 35 to 54 Years
THURSDAY, Oct. 12, 2023 – The incidence of lung cancer is higher in women than men aged 35 to 54 years, according to a research letter published online Oct. 12 in JAMA Oncology. Ahmedin Jemal,...
When Lung Cancer Strikes the Young, Women Face Higher Risks Than Men
FRIDAY, Oct. 13, 2023 – New research uncovers troubling trends for lung cancer in young and middle-aged women. Cancer incidence in young women is higher than it is in men, a continuing trend, and...